Regulus Therapeutics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.3864 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
1.17 | 4.83 | -75.72% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.1331 | -22.17 | -99.4% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-0.1501 | 68.76 | -100.22% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | -86754.67 | -100% |
| ROE |
|
-141.77 | 9.61 | -1575% |
|
|
| ROA |
|
-97.68 | 0.3443 | -28474.33% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-146.83 | 15.45 | -1050.39% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1004 | -3.68 | -97.27% | -0.1388 | -27.62% |
| Nеt Debt/Ebitda |
|
0.6712 | -3.44 | -119.53% |
|
|
| Debt/Ratio |
|
0.1009 | 0.1986 | -49.2% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.1033 | 10.32 | -101% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-86.11 | -57.64 | 49.39% | ||
| Growth impulse Ebitda in 5 years |
|
83.82 | -90.94 | -192.17% | ||
| Growth impulse Net Income in 5 years |
|
61.49 | -97.8 | -162.87% | ||
| Growth impulse FCF in 5 years |
|
36.22 | -108.72 | -133.31% | ||
| Growth impulse EPS in 5 years |
|
-85.29 | -142.05 | -39.96% |
IP Score
3.57/10
